Ingaron (recombinant human interferon-gamma) / Pharmaclon - LARVOL DELTA

The 1st Tumor CytokinoTherapy Database (TCTD-1) (clinicaltrials.gov) - P=N/A | N=5000 | Recruiting | Sponsor: OncoCareClinic 308 Ltd

New trial • Gene Therapies • Oncology

Clinical Testing of the Drug Ingaron as Part of Complex Therapy in Adult Patients With Tuberculosis (clinicaltrials.gov) - P=N/A | N=350 | Recruiting | Sponsor: SPP Pharmaclon Ltd.

New trial • Infectious Disease • Pulmonary Disease • Respiratory Diseases • Tuberculosis • CD4

Study on the Use of Interferon Gamma (Ingaron) Injections in Patients With Drug-resistant Pulmonary Tuberculosis (clinicaltrials.gov) - P=N/A | N=84 | Recruiting | Sponsor: SPP Pharmaclon Ltd. | Enrolling by invitation ➔ Recruiting

Enrollment status • Infectious Disease • Pulmonary Disease • Respiratory Diseases • Tuberculosis • CD4 • CD8

Study of Ingaron's Effect on Efficacy and Resistance to Antibiotics in Community-acquired Pneumonia (clinicaltrials.gov) - P=N/A | N=114 | Completed | Sponsor: SPP Pharmaclon Ltd.

New trial • Infectious Disease • Pneumonia • CRP

Study of the Use of the Drug Ingaron in Patients With COVID-19 (clinicaltrials.gov) - P=N/A | N=36 | Completed | Sponsor: SPP Pharmaclon Ltd.

New trial • Infectious Disease • Novel Coronavirus Disease • Pneumonia • Respiratory Diseases